Home/Filings/4/0001209191-14-002371
4//SEC Filing

IDERA PHARMACEUTICALS, INC. 4

Accession 0001209191-14-002371

CIK 0000861838operating

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 4:12 PM ET

Size

5.5 KB

Accession

0001209191-14-002371

Insider Transaction Report

Form 4
Period: 2014-01-06
BRENNER LOUIS MD
Chief Medical Officer
Transactions
  • Award

    Stock Option

    2014-01-06+600,000600,000 total
    Exercise: $5.04Exp: 2024-01-06Common Stock (600,000 underlying)
Footnotes (1)
  • [F1]The option vests with respect to 25% of the underlying shares beginning on the first anniversary of the date of grant and the balance of the shares vests in twelve equal quarterly installments following the first anniversary of the date of grant.

Issuer

IDERA PHARMACEUTICALS, INC.

CIK 0000861838

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000861838

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:12 PM ET
Size
5.5 KB